Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Tenax Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −3 vs. Q4 2021
- Shares held
- 8.08M
- +19.8K (+0.2%) vs. Q4 2021
- Total value
- $6.54M
- −$1.84M (−22.0%) vs. Q4 2021
- New holders
- 0
- 4 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 24 | $0 | 0.00% | −4,787−99.5% | Reduced |
| Wells Fargo & Company | 92 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 12 | $0 | 0.00% | +11+1,100.0% | Added |
| Umb Bank N A | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Horan Securities, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Planning LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,822 | $4.00K | 0.00% | +77+1.6% | Added |
| HRT Financial LP | 10,658 | $8.00K | 0.00% | −2,610−19.7% | Reduced |
| Northern Trust Corp | 34,671 | $28.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 51,212 | $41.0K | 0.00% | 00.0% | Unchanged |
| Financial Advisory Service, Inc. | 58,326 | $47.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 67,432 | $55.0K | 0.00% | −13,000−16.2% | Reduced |
| Boothbay Fund Management, LLC | 71,808 | $58.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 138,407 | $112.0K | 0.00% | +2,003+1.5% | Added |
| The PNC Financial Services Group, Inc. | 200,000 | $162.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 358,978 | $290.0K | 0.00% | −1,091−0.3% | Reduced |
| BlackRock Inc. | 510,718 | $413.0K | 0.00% | −1,566−0.3% | Reduced |
| Ikarian Capital, LLC | 735,097 | $596.0K | 0.18% | +40,902+5.9% | Added |
| Armistice Capital, LLC | 2,019,995 | $1.64M | 0.05% | 00.0% | Unchanged |
| Gofen & Glossberg LLC | 3,819,170 | $3.09M | 0.07% | 00.0% | Unchanged |
| Bank of America Corp | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Confluence Wealth Services, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |